Safety and Efficacy of Carbohydrate Drink Ingested Two Hours Before Upper Endoscopy Under General Anaesthesia
NCT ID: NCT01471600
Last Updated: 2013-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
119 participants
INTERVENTIONAL
2008-05-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Drinking Carbohydrate-containing Fluids on Gastric Residual Volume in Elderly Patients
NCT04514380
Gastric Volume in Elderly Patients Undergoing Staged Bilateral Total Knee Arthroplasty
NCT04814706
Effects of Drinking at PACU Discharge After General Anaesthesia With Airway Control on Aspiration, Vomiting and Patients Comfort
NCT02193737
Impact of Preoperative Fasting on Intraoperative Glycemic Homeostasis and Enhanced Recovery in Children
NCT04826627
Effects of Preoperative Oral Carbohydrates Loading in Patients at High Risk of Postoperative Nausea and Vomiting Undergoing Spinal Surgery
NCT02809950
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No intervention
Group overnight fasting
No interventions assigned to this group
Group drink
Glucose drink (200 ml of fruit juice without pulp, ± 200ml coffee or tea, 2 at 4 hours before induction of anaesthesia)
group drink
group glucose drink : 200 ml of fruit juice without pulp, ± 200ml coffee or tea, 2 at 4 hours before induction of anaesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
group drink
group glucose drink : 200 ml of fruit juice without pulp, ± 200ml coffee or tea, 2 at 4 hours before induction of anaesthesia
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* undergoing upper endoscopy procedure under general anesthesia without emergency
* informed written consent
Exclusion Criteria
* might impair gastrointestinal motility (intestinal obstruction, stenosis)
* diseases of the central and peripheral nervous system or neuromuscular diseases
* drug-induced gastric emptying disorders
* pregnancy
* ionic disorders (hyponatremia\<125mmol/l ; hypokalemia\<3,5mmol/l
* hemodynamic disorders (systolic arterial pressure \<100mmHg)
* unstable diabetes (glycemia\>2,5g/l) ± insulin- dependent diabetes ± diabetic gastroparesis
* the potential for difficult airway management
* understanding of the information
* patient with bad prognosis
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie A PIQUET, PhD MD
Role: PRINCIPAL_INVESTIGATOR
CAEN, Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Caen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-009
Identifier Type: OTHER
Identifier Source: secondary_id
2008-A00255-50
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.